Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.

MLA

Sutiman, Natalia, et al. “Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.” PloS One, vol. 11, no. 5, May 2016, p. e0154316. EBSCOhost, https://doi.org/10.1371/journal.pone.0154316.

APA

Sutiman, N., Zhang, Z., Tan, E. H., Ang, M. K., Tan, S.-W. D., Toh, C. K., Ng, Q. S., Chowbay, B., & Lim, W.-T. (2016). Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules. PloS One, 11(5), e0154316. https://doi.org/10.1371/journal.pone.0154316

Chicago

Sutiman, Natalia, Zhenxian Zhang, Eng Huat Tan, Mei Kim Ang, Shao-Weng Daniel Tan, Chee Keong Toh, Quan Sing Ng, Balram Chowbay, and Wan-Teck Lim. 2016. “Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.” PloS One 11 (5): e0154316. doi:10.1371/journal.pone.0154316.